Abstract
Arsenical Drugs In article number 2102054, Aiguo Wu, Tian Xie, Wei Tao, and co-workers reveal PEGylated arsenene nanodots (AsNDs@PEG) with high monoelemental arsenic purity and negligible systemic toxicity as a new-concept arsenical drug. This AsNDs@PEG, when applied in a low-dose combination strategy with β-elemene, a plant-derived anticancer drug, achieves synergistic therapeutic outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
